| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH | | | RGO 2020-1 (USD 2,000m) | Regeneron Pharmaceuticals Inc | | USOA | Aug 7, 2020 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| UME | 142.000 | 83 | Jul-43 | Xy. Hkboeryos | Aqq3 | YYY+ | - | Jzrbh | Ozv | Q+180 s | - | 160 | 2.80% | - | 51.37200 | | YPB | 5,562.000 | 81 | Aug-17 | Nr. Axzigrris | Gtt3 | QQQ+ | - | Zjwxy | Cfm | K+140 s | - | 120 | 1.75% | - | 59.21800 |
Tranche Comments 10 my: Book size: 2708; First Pay: 2021-03-15; Registration: Jxfolpxhxc; Comments: NL$1.25iz 1.75% gqz 10bo (9/15/30) kh 99.898, boe 1.761%. B+120iq. UON B+20iq;
30 bv: Book size: 1464; First Pay: 2021-03-15; Registration: Typqlsynyu; Comments: NX$750u 2.80% cpp 30cf (9/15/50) er 99.715, cvd 2.814%. B+160tp. TIQ B+25tp; Use of Proceeds Smqxk ymvpvxesyea syxep |
|
